Mosaic tumor vessels: Cellular basis and ultrastructure of focal regions lacking endothelial cell markers

被引:86
作者
di Tomaso, E
Capen, D
Haskell, A
Hart, J
Logie, JJ
Jain, RK
McDonald, DM
Jones, R
Munn, LL
机构
[1] Harvard Univ, Sch Med, Dept Radiat Oncol, Steele Lab Tumor Biol, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Dept Anesthesia & Crit Care, Steele Lab Tumor Biol, Boston, MA 02114 USA
[3] Massachusetts Gen Hosp, Boston, MA 02114 USA
[4] Univ Calif San Francisco, Cardiovasc Res Inst, Ctr Comprehens Canc, San Francisco, CA 94143 USA
[5] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA
关键词
D O I
10.1158/0008-5472.CAN-04-4552
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Endothelial cells of blood vessels in tumors may be thin, fragile, and defective in barrier function. We found previously that the endothelium of vessels in human colon carcinoma xenografts in mice is a mosaic structure. Approximately 85% of tumor vessels have uniform CD31 and/or CD105 immunoreactivity, but the remainder have focal regions that lack these common endothelial markers. The present study assessed the ultrastructure of the vessel lining and the integrity of the basement membrane in these regions. Using immunolabeling and confocal microscopy, we identified blood vessels that lacked CD31 and CD105 immunoreactivity and then analyzed the ultrastructure of these vessels by transmission electron microscopy. Eleven percent of vessels in orthotopic tumors and 24% of vessels in ectopic tumors had defects in CD31 and CD105 staining measuring on average 10.8 mu m (range, 1-41.2 mu m). Ultrastructural studies identified endothelial cells at 92% of CD31- and CD105-negative sites in orthotopic tumors and 70% of the sites in ectopic tumors. Thus, most regions of tumor vessels that lack CD31 and CD105 immunoreactivity represent attenuated endothelial cells with abnormal expression of endothelial cell markers, but some are gaps between endothelial cells. More than 80% of the defects lacked immunoreactivity for multiple basement membrane proteins.
引用
收藏
页码:5740 / 5749
页数:10
相关论文
共 36 条
[1]   Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors [J].
Baluk, P ;
Morikawa, S ;
Haskell, A ;
Mancuso, M ;
McDonald, DM .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (05) :1801-1815
[2]   Cellular abnormalities of blood vessels as targets in cancer [J].
Baluk, P ;
Hashizume, H ;
McDonald, DM .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2005, 15 (01) :102-111
[3]  
Browder T, 2000, CANCER RES, V60, P1878
[4]   Mosaic blood vessels in tumors: Frequency of cancer cells in contact with flowing blood [J].
Chang, YS ;
di Tomaso, E ;
McDonald, DM ;
Jones, R ;
Jain, RK ;
Munn, LL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (26) :14608-14613
[5]   Ultrastructural localization of platelet endothelial cell adhesion molecule (PECAM-1, CD31) in vascular endothelium [J].
Feng, D ;
Nagy, JA ;
Pyne, K ;
Dvorak, HF ;
Dvorak, AM .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2004, 52 (01) :87-101
[6]  
Fukumura D, 1997, AM J PATHOL, V151, P679
[7]  
HAMMERSEN F, 1985, INT J MICROCIRC, V4, P31
[8]   Openings between defective endothelial cells explain tumor vessel leakiness [J].
Hashizume, H ;
Baluk, P ;
Morikawa, S ;
McLean, JW ;
Thurston, G ;
Roberge, S ;
Jain, RK ;
McDonald, DM .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (04) :1363-1380
[9]   Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment [J].
Hobbs, SK ;
Monsky, WL ;
Yuan, F ;
Roberts, WG ;
Griffith, L ;
Torchilin, VP ;
Jain, RK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (08) :4607-4612
[10]   Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF [J].
Holash, J ;
Maisonpierre, PC ;
Compton, D ;
Boland, P ;
Alexander, CR ;
Zagzag, D ;
Yancopoulos, GD ;
Wiegand, SJ .
SCIENCE, 1999, 284 (5422) :1994-1998